"But Dr Goh's desire to present is mainly related to his/her's research career, and not an invested interest in Cvac."
IMO thats why the data to be presented is going to be very important and in terms of credibility. Its not just a management spiel to investors but a scientific assessment of trial results,so far. As Dr Frazer has advised it will be interim results from all CAN003 sites. I just hope they reflect hope for ovarian cancer sufferers and if they do, imo as an investor I am more likely to gain.
cheers
"But Dr Goh's desire to present is mainly related to his/her's...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 133736 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |